Efficacy of Responder-derived Fecal Microbiota Transplant (R-FMT) and Pembrolizumab in Anti-PD-1 Refractory Patients with Advanced Melanoma.

Davar, D; Dzutsev, A; McCulloch, JA; Rodrigues, RR; Chauvin, JM; Morrison, RM; Deblasio, RN; Menna, C; Ding, QQ; Pagliano, O; Zidi, B; Zhang, SW; Badger, JH; Vetizou, M; Cole, AM; Fernandes, MR; Prescott, S; Costa, RG; Balaji, AK; Morgun, A; Vujkovic-Cvijin, I; Wang, H; Borhani, AA; Schwartz, MB; Dubner, HM; Ernst, SJ; Rose, A; Najjar, YG; Belkaid, Y; Kirkwood, JM; Trinchieri, G; Zarour, HM

CANCER RESEARCH, 2021; 81 (13):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索